The VAI status indicates that there are no such complying issues with the facility; hence, the USFDA will not take any regulatory or administrative action against the facility.

I’ve said this before: I’m no eye-cream evangelist. I’m a firm believer that your regular moisturizer should work just fine for the skin under your eyes as long as it isn’t too heavy and ...

Avoid rubbing or pressing on your eye. Your doctor may prescribe antibiotic eye drops or ointment to keep your eye from getting infected. They might also give you medicated eye drops to ease pain ...

Rationale The most common antibiotic used to treat people with cystic fibrosis (PWCF) is inhaled tobramycin, administered as maintenance therapy for chronic Pseudomonas aeruginosa lung infections.

The AKI was initially attributed to intravenous vancomycin. Despite discontinuing vancomycin, the AKI worsened. A tobramycin level was collected and resulted at 5.5 µg/mL. Due to high suspicion for ...

Have you ever wondered if VR is bad for your eyes? Here's what experts have to say about virtual reality headsets. Jessica was a writer on the Wellness team, with a focus on health technology, eye ...

In many cases, home remedies and over-the-counter eye drops can relieve red eyes. But if symptoms linger or are accompanied by pain or vision problems, you should see an ophthalmologist. University of ...

The equity benchmarks maintained their upward momentum in Thursday afternoon trading, with both the Sensex and Nifty posting gains amid mixed global cues following the US Federal Reserve’s rate ...

Cipla Q3 results review: The shares of the third largest pharmaceutical firm Cipla rose 2.44 per cent at Rs 1,454.20 a piece on the BSE intraday after the company delivered a solid quarterly earnings ...

Shares of drugmaker Cipla Ltd. surged to the day's high, gaining as much as 4% after the company's December quarter results. The results were a beat across parameters.

Cipla Ltd. has expressed optimism about exceeding its FY25 guidance, supported by strong operational performance and a focused strategy. The company stated that supply challenges related to Lanreotide ...

HYDERABAD/BENGALURU (Reuters) -Cipla, one of India's largest drugmakers by sales, reported a bigger-than-expected third-quarter profit on Tuesday helped by strong domestic demand, and said the U.S ...